Up 160% in a year, why this ASX 200 healthcare stock is surging again today

Pro Medicus Limited (ASX: PME) shares are having a good start to the session. In morning trade, the ASX 200 …

| More on:
Shot of a young scientist using a digital tablet while working in a lab.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Pro Medicus Limited (ASX: PME) shares are having a good start to the session.

In morning trade, the ASX 200 healthcare stock is up 3% to $261.50.

This builds on the 160% gain the health imaging technology company's shares had already recorded over the past 12 months.

Why is this ASX 200 healthcare stock surging?

Investors have been bidding the Pro Medicus share price higher today for a couple of reasons.

One reason is that Wall Street rallied higher overnight thanks to the release of favourable inflation data. This is giving the whole market a big boost this morning.

In addition, investors are responding positively to the release of an announcement from the ASX 200 healthcare stock today.

According to the release, the company has signed a $33 million, 9-year contract with the University of Kentucky (UK). It is the preeminent academic health system in the state of Kentucky.

The company notes that UK HealthCare is a comprehensive healthcare system that includes a network of hospitals, clinics, and specialised medical services. It is anchored by the UK Albert B. Chandler Hospital, which is a leading medical facility in the region, offering advanced treatment options and cutting-edge research.

It also highlights that the system includes the UK Good Samaritan Hospital, which provides a range of services including emergency care, surgery, and rehabilitation. Furthermore, it is affiliated with the University of Kentucky College of Medicine, ensuring a strong emphasis on education, research, and innovation.

What's the contract?

The release reveals that the contract is based on a transactional licensing model and will see the company's cloud-based Visage 7 Enterprise Imaging Platform, including Visage 7 Open Archive and Visage 7 Workflow modules, implemented throughout UK providing a unified diagnostic imaging platform.

Visage will complete the migration from UK's legacy PACS archive and vendor neutral archive to Visage 7 Open Archive. Visage 7 will also provide enterprise distribution of images integrated to UK's electronic health record (EHR).

Commenting on this latest contract win, the ASX 200 healthcare stock's CEO, Dr Sam Hupert, said:

University of Kentucky joins our growing list of academic clients. They also join a long list of Visage 7 clients to opt for a fully cloud-based solution, which, as a result of our CloudPACS strategy, is becoming the standard in the North American healthcare IT market.

Our pipeline remains strong and spans all market segments. As has been the case with many of our recent contracts, this deal is for our "full stack" comprising all three Visage products namely viewer, workflow and archive, a trend we see continuing.

Motley Fool contributor James Mickleboro has positions in Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Ecstatic woman looking at her phone outside with her fist pumped.
Broker Notes

These ASX 200 shares could rise 15% to 30%

Let's see what brokers are saying about these buy-rated top stocks.

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a rough start to the trading week for investors this Monday.

Read more »

A female stockbroker reviews share price performance in her office with the city shown in the background through her windows
Broker Notes

JP Morgan initiates coverage of Guzman Y Gomez shares. What's its price target?

Does the broker expect Guzman Y Gomez to outperform?

Read more »

two computer geeks sit across from each other with their laptop computers touching as they look confused and confounded by what they are seeing on their screens.
Share Gainers

ASX tech shares outperformed US tech stocks by 2:1 in FY25. Here's why

Forget the Magnificent 7! Aussie tech shares had twice as much price growth as US tech stocks in FY25.

Read more »

Person pretends to types on laptop drawn in sand.
Opinions

I sold one of my oldest ASX 200 shares last week. Here's why

Why would I sell one of my longest-held stocks?

Read more »

Happy man working on his laptop.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

Worker on a laptop at an oil and gas pipeline.
Energy Shares

Boss Energy shares have surged 93% since April. Here's what Macquarie expects now

Boss Energy shares remain a favourite for ASX short sellers. Are they in a for a payday or headed for…

Read more »

Bored man sitting at his desk with his laptop.
Share Fallers

Why Antipa Minerals, Northern Star, Pilbara Minerals, and Synlait Milk shares are falling today

These shares are starting the week in the red. But why?

Read more »